Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Heart patients treated by non-cardiologists less likely to receive medications

14.01.2005


Patients with congestive heart failure (CHF) are less likely to be discharged from the hospital with a prescription for an ACE inhibitor and other recommended medications if they are treated by a non-cardiologist, according to a study written by pharmacists at Northwestern Memorial Hospital and published January 15 in the American Journal of Health-System Pharmacy. Beta-blockers, ACE inhibitors, and aldosterone antagonists have been shown to significantly decrease morbidity and mortality and are among the medications recommended by the Heart Failure Society of America (HFSA) to treat CHF, which affects nearly 5 million Americans.



Prescribing differences were demonstrated for several key medications, including:

  • ACE inhibitor (prescribed for 61 percent of patients upon discharge by cardiologists versus 35 percent by non-cardiologists)
  • Beta-blocker (prescribed for 65 percent of patients upon discharge by a cardiologist versus 32 percent by non-cardiologists)
  • Aldosterone antagonist (prescribed for 17 percent of patients upon discharge by a cardiologist versus 7 percent by non-cardiologists)

The study also found that cardiologists are more likely to admit a CHF patient to the Intensive Care Unit and order diagnostic tests, including chest x-rays, electrocardiograms, nuclear medicine tests, cardiac catheterizations, and stress tests, without significantly increasing a patient’s length of stay.

Study authors urge patients to take an active role in their treatment and ask about available medications. "Furthermore, patients or their family members should ask to speak to the hospital pharmacist whenever they have questions about their medicine," explains Jean A. Patel, Pharm. D., clinical pharmacist at Northwestern Memorial Hospital and lead author of the study.


The study was co-authored by Michael A. Fotis, B.S. Pharm, manager of drug information service at Northwestern Memorial Hospital.

Patty Keiler | EurekAlert!
Further information:
http://www.nmh.org
http://www.ashp.org
http://www.SafeMedication.com

More articles from Studies and Analyses:

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

nachricht New study from the University of Halle: How climate change alters plant growth
12.01.2018 | Martin-Luther-Universität Halle-Wittenberg

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

Im Focus: Hybrid optics bring color imaging using ultrathin metalenses into focus

For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.

But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...

Im Focus: Stem cell divisions in the adult brain seen for the first time

Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.

The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...

Im Focus: Interference as a new method for cooling quantum devices

Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters

Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Researchers invent tiny, light-powered wires to modulate brain's electrical signals

21.02.2018 | Life Sciences

The “Holy Grail” of peptide chemistry: Making peptide active agents available orally

21.02.2018 | Life Sciences

Atomic structure of ultrasound material not what anyone expected

21.02.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>